Literature DB >> 12668303

Comparison of six clinically used external defibrillators in swine.

Robert G Walker1, Sharon B Melnick, Fred W Chapman, Gregory P Walcott, Paul W Schmitt, Raymond E Ideker.   

Abstract

BACKGROUND: External defibrillation has long been practiced with two types of monophasic waveforms, and now four biphasic waveforms are also widely available. Although waveforms and clinical dosing protocols differ among defibrillators, no studies have adequately compared performance of the monophasic or the biphasic waveforms. This is the first study to compare defibrillation efficacy among biphasic external defibrillators, and does so as part of a study comparing all commonly available waveforms using their respective manufacturer-provided and clinically used doses. METHODS AND
RESULTS: Efficacy of six waveforms was tested in 852 short-duration ventricular fibrillation episodes in 14 swine. Protocol 1: 200-J monophasic damped sine (MDS) and monophasic truncated exponential (MTE) shocks were compared to 150-J biphasic shocks in six swine at the low-impedance of these animals. Protocol 2: Four commercially available biphasic defibrillators were compared using their respective manufacturer-recommended dose protocols in eight swine at low and simulated high-impedance. At low-impedance, all biphasic shocks achieved near-perfect success, while efficacy was significantly lower for MDS (67%) and MTE (30%) shocks. In protocol 2, first-shock success rates of the four biphasic defibrillators were uniformly high (97, 100, 100, and 94%) for low-impedance shocks, and decreased for high-impedance shocks (62, 92, 82, and 64%). There were statistically significant differences in efficacy among devices.
CONCLUSIONS: Commonly used MDS and MTE waveforms provide markedly dissimilar efficacies. Despite impedance-compensation schemes in biphasic defibrillators, impedance has an impact on their efficacy. At high-impedance, modest efficacy differences exist among clinically available biphasic defibrillators, reflecting differences in both waveforms and manufacturer-provided doses.

Entities:  

Mesh:

Year:  2003        PMID: 12668303     DOI: 10.1016/s0300-9572(02)00404-5

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  5 in total

Review 1.  Theory and practice of defibrillation: (2) defibrillation for ventricular fibrillation.

Authors:  A A J Adgey; M S Spence; S J Walsh
Journal:  Heart       Date:  2005-01       Impact factor: 5.994

2.  Association between transthoracic impedance and electrical cardioversion success with biphasic defibrillators: An analysis of 1055 shocks for atrial fibrillation and flutter.

Authors:  Mouhannad M Sadek; Varsha Chaugai; Mark J Cleland; Timothy J Zakutney; David H Birnie; F Daniel Ramirez
Journal:  Clin Cardiol       Date:  2018-05-11       Impact factor: 2.882

3.  Role of peak current in conversion of patients with ventricular fibrillation.

Authors:  Venkataraman Anantharaman; Paul Weng Wan; Seow Yian Tay; Peter George Manning; Swee Han Lim; Siang Jin Terrance Chua; Tiru Mohan; Antony Charles Rabind; Sudarshan Vidya; Ying Hao
Journal:  Singapore Med J       Date:  2017-07       Impact factor: 1.858

Review 4.  Ventricular fibrillation and defibrillation.

Authors:  P Jones; N Lodé
Journal:  Arch Dis Child       Date:  2007-10       Impact factor: 3.791

Review 5.  [Transthoracic defibrillation. Physiologic and pathophysiologic principles and their role in the outcome of resuscitation].

Authors:  V Lischke; P Kessler; C Byhahn; K Westphal; A Amann
Journal:  Anaesthesist       Date:  2004-02       Impact factor: 1.041

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.